Mentions
Extended reach
Total likes
Video views
AI synopsis
The groups of discussions show a strong focus on the positive findings, such as reductions in depression severity and anxiety, with phrases like 'sustained improvements' and 'reductions in severity' indicating genuine interest. They also consider limitations like the observational nature, demonstrating thoughtful engagement with the research’s implications and cautious optimism about its impact.
Most discussions support the positive outcomes reported in the study, though some caution that causality isn't proven.
Posts show high interest, mentioning specific data points like depression reductions at 1, 3, and 6 months and highlighting clinical implications.
Several posts reference the research methods, such as longitudinal and observational study designs, and discuss clinical relevance, indicating deep engagement.
The discussions suggest this research influences perceptions about medicinal cannabis’s role in treating depression, though not transformational policy-wise.
Tratamiento con cannabis se asoció a reducción de gravedad de la depresión a los 1, 3 y 6 meses. Es un estudio observacional y no demuestra una relación causal. “Este análisis aporta ideas para estudios posteriores en el contexto de ensayos clínicos”. https://t.co/GAQh1rblCN
Authors concluded that cannabis treatment “was associated with reductions in depression severity at 1, 3, and 6 months.” Assessment of clinical outcomes of medicinal cannabis therapy for depression: Analysis from the UK Medical Cannabis Registry https://t.co/pXai5Uip7n
Fantastic study, led by @ImperialMCRG student Sajed on outcomes for patients with depression prescribed medical cannabis Particularly nice to have the ability to write a plain summary to make the research more accessible Read the full study here: https://t.co/I6WJcvSRGr https://t.co/BvmF2ZDVXU
About what patients who use #cannabis for #depression state: "Median decrease in PHQ-9 from baseline was 4.0, 5.0, and 4.0 after 1, 3, and 6 months, respectively...reductions..were observed in approximately 50% of patients across all follow-up intervals" https://t.co/HtH6aoMDJ8
Studio: Il consumo quotidiano di prodotti di #cannabis è associato a miglioramenti sostenuti dei sintomi depressivi. https://t.co/1RN4vSgnKv Dati pubblicati sulla rivista Expert Review of Neurotherapeutics
What happens when you go to sleep high? This video explores how THC and CBD influence your sleeping brain, shedding light on their effects. Tune in for a deeper understanding of cannabis and its impact on sleep health.
In this video, we explore how cannabis interacts with our body's natural sleep cycles and its effects on sleep quality. We discuss the latest findings and studies that shed light on this complex relationship. Discover…
This video explores the question: Does cannabis help with sleep? It references multiple studies and resources that assess the efficacy of medicinal cannabis therapy, particularly in relation to mental health and sleep…
Research has found positive link between cannabis use and depression, but it's unclear whether cannabis use leads to depression or vice versa. This longitudinal study found very large decreases in depression following medical cannabis use https://t.co/yzBD1H3tLI
This is all they have. "I can" and personal anecdotes. https://t.co/RCI60lhF9o but alas it does help with depression in many people. It comes down to "I don't like it so no freedom for you!" My doctor and psych know I use cannabis and have no issue. Alcohol is way worse. https://t.co/jb9IIydF5l https://t.co/hSQkMzalGm
RT @Simon_Erridge: Fantastic study, led by @ImperialMCRG student Sajed on outcomes for patients with depression prescribed medical cannabis…
RT @MaryNewsWeb:
RT @MaryNewsWeb:
RT @MaryNewsWeb:
RT @MaryNewsWeb:
RT @MaryNewsWeb:
RT @MaryNewsWeb:
RT @MaryNewsWeb:
RT @Simon_Erridge: Fantastic study, led by @ImperialMCRG student Sajed on outcomes for patients with depression prescribed medical cannabis…
RT @fundacioncanna: Assessment of clinical outcomes of #medicinalcannabis therapy for #depression: analysis from the UK Medical Cannabis Re…
RT @pitiklinov: Tratamiento con cannabis se asoció a reducción de gravedad de la depresión a los 1, 3 y 6 meses. Es un estudio observacion…
RT @pitiklinov: Tratamiento con cannabis se asoció a reducción de gravedad de la depresión a los 1, 3 y 6 meses. Es un estudio observacion…
RT @pitiklinov: Tratamiento con cannabis se asoció a reducción de gravedad de la depresión a los 1, 3 y 6 meses. Es un estudio observacion…
RT @pitiklinov: Tratamiento con cannabis se asoció a reducción de gravedad de la depresión a los 1, 3 y 6 meses. Es un estudio observacion…
Assessment of clinical outcomes of #medicinalcannabis therapy for #depression: analysis from the UK Medical Cannabis Registry. Medicinal #Cannabis treatment was associated with reductions in depression severity at 1, 3, and 6 months. More research needed. https://t.co/nR2OiW6BrB https://t.co/274Rt5DAQT
RT @pitiklinov: Tratamiento con cannabis se asoció a reducción de gravedad de la depresión a los 1, 3 y 6 meses. Es un estudio observacion…
RT @pitiklinov: Tratamiento con cannabis se asoció a reducción de gravedad de la depresión a los 1, 3 y 6 meses. Es un estudio observacion…
RT @pitiklinov: Tratamiento con cannabis se asoció a reducción de gravedad de la depresión a los 1, 3 y 6 meses. Es un estudio observacion…
RT @pitiklinov: Tratamiento con cannabis se asoció a reducción de gravedad de la depresión a los 1, 3 y 6 meses. Es un estudio observacion…
RT @pitiklinov: Tratamiento con cannabis se asoció a reducción de gravedad de la depresión a los 1, 3 y 6 meses. Es un estudio observacion…
RT @pitiklinov: Tratamiento con cannabis se asoció a reducción de gravedad de la depresión a los 1, 3 y 6 meses. Es un estudio observacion…
RT @pitiklinov: Tratamiento con cannabis se asoció a reducción de gravedad de la depresión a los 1, 3 y 6 meses. Es un estudio observacion…
RT @pitiklinov: Tratamiento con cannabis se asoció a reducción de gravedad de la depresión a los 1, 3 y 6 meses. Es un estudio observacion…
RT @pitiklinov: Tratamiento con cannabis se asoció a reducción de gravedad de la depresión a los 1, 3 y 6 meses. Es un estudio observacion…
Tratamiento con cannabis se asoció a reducción de gravedad de la depresión a los 1, 3 y 6 meses. Es un estudio observacional y no demuestra una relación causal. “Este análisis aporta ideas para estudios posteriores en el contexto de ensayos clínicos”. https://t.co/GAQh1rblCN
Study: Assessment of clinical outcomes of medicinal cannabis therapy for depression: analysis from the UK Medical Cannabis Registry - ERN https://t.co/bMgzqbh60v CBMP treatment was associated with reductions in depression severity at 1, 3, and 6 months.
RT @Simon_Erridge: Fantastic study, led by @ImperialMCRG student Sajed on outcomes for patients with depression prescribed medical cannabis…
RT @Simon_Erridge: Fantastic study, led by @ImperialMCRG student Sajed on outcomes for patients with depression prescribed medical cannabis…
RT @Simon_Erridge: Fantastic study, led by @ImperialMCRG student Sajed on outcomes for patients with depression prescribed medical cannabis…
Fantastic study, led by @ImperialMCRG student Sajed on outcomes for patients with depression prescribed medical cannabis Particularly nice to have the ability to write a plain summary to make the research more accessible Read the full study here: https://t.co/I6WJcvSRGr https://t.co/BvmF2ZDVXU
RT @Peter_Grinspoon: About what patients who use #cannabis for #depression state: "Median decrease in PHQ-9 from baseline was 4.0, 5.0, an…
RT @tandfnewsroom: Daily consumption of medically-prescribed cannabis products could be associated with sustained improvements in depressiv…
Daily consumption of medically-prescribed cannabis products could be associated with sustained improvements in depressive symptoms, a new study suggests. Findings from @DrMSodergren, et al, also saw a regression in symptoms of anxiety. More
RT @BellevueDoc: Authors concluded that cannabis treatment “was associated with reductions in depression severity at 1, 3, and 6 months.”…
RT @Peter_Grinspoon: About what patients who use #cannabis for #depression state: "Median decrease in PHQ-9 from baseline was 4.0, 5.0, an…
RT @MaryNewsWeb: @istsupsan @Aifa_ufficiale @MinisteroSalute @GiorgiaMeloni @Quirinale @LegaleMeglio @Blowjoint @AnnaK4202 @acino2020 @klau…
@istsupsan @Aifa_ufficiale @MinisteroSalute @GiorgiaMeloni @Quirinale @LegaleMeglio @Blowjoint @AnnaK4202 @acino2020 @klaudioz83 more info: .https://t.co/1RN4vSfPUX .https://t.co/UGGQURs2U6 .https://t.co/JvYF6SB5Cz #Cannabis #WeedMob #SpiniNelFianco
RT @BellevueDoc: Authors concluded that cannabis treatment “was associated with reductions in depression severity at 1, 3, and 6 months.”…
Évaluation des résultats cliniques de la thérapie au cannabis médicinal pour la dépression : analyse du UK Medical Cannabis Registry https://t.co/bu5eiknslg https://t.co/2fYjzHdn2e
Studio: Il consumo quotidiano di prodotti di #cannabis è associato a miglioramenti sostenuti dei sintomi depressivi. https://t.co/1RN4vSgnKv Dati pubblicati sulla rivista Expert Review of Neurotherapeutics
RT @BellevueDoc: Authors concluded that cannabis treatment “was associated with reductions in depression severity at 1, 3, and 6 months.”…
RT @ImperialMCRG:
RT @BellevueDoc: Authors concluded that cannabis treatment “was associated with reductions in depression severity at 1, 3, and 6 months.”…
RT @BellevueDoc: Authors concluded that cannabis treatment “was associated with reductions in depression severity at 1, 3, and 6 months.”…
RT @BellevueDoc: Authors concluded that cannabis treatment “was associated with reductions in depression severity at 1, 3, and 6 months.”…
RT @BellevueDoc: Authors concluded that cannabis treatment “was associated with reductions in depression severity at 1, 3, and 6 months.”…
RT @BellevueDoc: Authors concluded that cannabis treatment “was associated with reductions in depression severity at 1, 3, and 6 months.”…
RT @BellevueDoc: Authors concluded that cannabis treatment “was associated with reductions in depression severity at 1, 3, and 6 months.”…
Authors concluded that cannabis treatment “was associated with reductions in depression severity at 1, 3, and 6 months.” Assessment of clinical outcomes of medicinal cannabis therapy for depression: Analysis from the UK Medical Cannabis Registry https://t.co/pXai5Uip7n
RT @Peter_Grinspoon: About what patients who use #cannabis for #depression state: "Median decrease in PHQ-9 from baseline was 4.0, 5.0, an…
About what patients who use #cannabis for #depression state: "Median decrease in PHQ-9 from baseline was 4.0, 5.0, and 4.0 after 1, 3, and 6 months, respectively...reductions..were observed in approximately 50% of patients across all follow-up intervals" https://t.co/HtH6aoMDJ8
PM
JM
SE
GD
MN
JJ
ST
BA
AA
V
P
LM
SQ
M
PB
TK
N
MR
F
SG
ÁR
FC
C
LH
DM
G
M
DM
A
R
U
EA
UA
IG
BW
SB
TN
ST
F
CF
TI
JM
PB
MC
GO
S
J
DR